Prevalence of Obstructive Sleep Apnea (OSA) and the Association With Cognitive Impairment
NCT ID: NCT04658290
Last Updated: 2024-02-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
500 participants
OBSERVATIONAL
2020-08-29
2026-08-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Obstructive Sleep Apnea on Glucose Control and Cognitive Function
NCT05108363
Sleep Apnea, Neurocognitive Decline and Brain Imaging in Patients With Subjective or Mild Cognitive Impairment
NCT06150352
A Study on the Prevalence of Obstructive Sleep Apnea in Patients With Type II Diabetes Mellitus
NCT01172093
A Cross-sectional Study of the Occurrence and Effect of Obstructive Sleep Apnea in Subjects With Resistant Hypertension
NCT00843583
Prospective Study on Patients With Obstructive Sleep Apnea in Hong Kong (PrOSA)
NCT04659291
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* A diagnosis of neurological disorders (e.g. Parkinson's Disease, Epilepsy, Multiple Sclerosis)
* Psychiatric disorders including current major depression; bipolar disorder; schizophrenia
* Other known clinically significant sleep disorders (e.g. narcolepsy)
* Been currently receiving CPAP or bi-level pressure for OSA
40 Years
74 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Chinese University of Hong Kong
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Susanna SS Ng
Assistant Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Chinese University of Hong
Hong Kong, Please Select, Hong Kong
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SleepBrain_2019
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.